Literature DB >> 3929307

Oxytocin diminishes heroin tolerance in mice.

G L Kovács, M Faludi, G Telegdy.   

Abstract

Tolerance was induced in mice to the antinociceptive effect of heroin by repeated subcutaneous injections of this narcotic analgesic for 3 days. Pretreatment of mice with daily doses of oxytocin (2-200 micrograms/kg body wt.) resulted in an attenuation of heroin tolerance. A single oxytocin injection prior to the first challenge with heroin was as active in attenuating heroin tolerance as daily treatments with the neuropeptide. A single injection of oxytocin prior to the least heroin challenge also attenuated the expression of tolerance. The neuropeptide failed to modify the acute antinociceptive effect of heroin. It is concluded, therefore, that oxytocin interferes with mechanisms involved in the development and expression of tolerance to heroin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3929307     DOI: 10.1007/bf00432233

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  Modulation of heroin self-administration by neurohypophyseal principles.

Authors:  J M Van Ree; D De Wied
Journal:  Eur J Pharmacol       Date:  1977-05-15       Impact factor: 4.432

Review 2.  Tolerance to, and dependence on, some non-opiate psychotropic drugs.

Authors:  H Kalant; A E LeBlanc; R J Gibbins
Journal:  Pharmacol Rev       Date:  1971-09       Impact factor: 25.468

Review 3.  Misleading concepts in the field of brain peptides.

Authors:  A J Kastin; J E Zadina; W A Banks; M V Graf
Journal:  Peptides       Date:  1984       Impact factor: 3.750

4.  Oxytocin reduces intravenous heroin self-administration in heroin-tolerant rats.

Authors:  G L Kovács; Z Borthaiser; G Telegdy
Journal:  Life Sci       Date:  1985-07-08       Impact factor: 5.037

5.  The development of tolerance to morphine in the rat.

Authors:  M Fernandes; S Kluwe; H Coper
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

6.  Absence of cross-tolerance to heroin in morphine-tolerant mice.

Authors:  D G Lange; S C Roerig; J M Fujimoto; R I Wang
Journal:  Science       Date:  1980-04-04       Impact factor: 47.728

7.  Effects of oxytocin and a derivative (Z-prolyl-D-leucine) on morphine tolerance/withdrawal are mediated by the limbic system.

Authors:  G L Kovács; F Izbéki; Z Horváth; G Telegdy
Journal:  Behav Brain Res       Date:  1984-10       Impact factor: 3.332

8.  Effects of oxytocin, des-glycinamide-oxytocin and anti-oxytocin serum on the alpha-MPT-induced disappearance of catecholamines in the rat brain.

Authors:  G Kovács; G Telegdy
Journal:  Brain Res       Date:  1983-06-06       Impact factor: 3.252

9.  Oxytocin affects utilization of noradrenaline in distinct limbic-forebrain regions of the rat brain.

Authors:  D van Heuven-Nolsen; E R De Kloet; D H Versteeg
Journal:  Neuropharmacology       Date:  1984-12       Impact factor: 5.250

10.  Oxytocin and a C-terminal derivative (Z-prolyl-D-leucine) attenuate tolerance to and dependence on morphine and interact with dopaminergic neurotransmission in the mouse brain.

Authors:  G L Kovács; Z Horváth; Z Sarnyai; M Faludi; G Telegdy
Journal:  Neuropharmacology       Date:  1985-05       Impact factor: 5.250

  10 in total
  8 in total

Review 1.  Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.

Authors:  Mary R Lee; Matthew C H Rohn; Gianluigi Tanda; Lorenzo Leggio
Journal:  CNS Drugs       Date:  2016-02       Impact factor: 5.749

2.  Chronic oxytocin administration as a tool for investigation and treatment: A cross-disciplinary systematic review.

Authors:  Marilyn Horta; Kathryn Kaylor; David Feifel; Natalie C Ebner
Journal:  Neurosci Biobehav Rev       Date:  2019-10-21       Impact factor: 8.989

Review 3.  Comparative studies of social buffering: A consideration of approaches, terminology, and pitfalls.

Authors:  Yasushi Kiyokawa; Michael B Hennessy
Journal:  Neurosci Biobehav Rev       Date:  2017-12-06       Impact factor: 8.989

Review 4.  Oxytocin and opioid addiction revisited: old drug, new applications.

Authors:  Panos Zanos; Polymnia Georgiou; Carol Weber; Fiona Robinson; Christos Kouimtsidis; Ramin Niforooshan; Alexis Bailey
Journal:  Br J Pharmacol       Date:  2017-04-06       Impact factor: 8.739

5.  Effects of oxytocin administration on fear-potentiated acoustic startle in co-occurring PTSD and alcohol use disorder: A randomized clinical trial.

Authors:  Christopher S Stauffer; Tyler E Morrison; Nathan K Meinzer; David Leung; Jessica Buffington; Evan G Sheh; Thomas C Neylan; Aoife O'Donovan; Joshua D Woolley
Journal:  Psychiatry Res       Date:  2021-12-12       Impact factor: 11.225

6.  Limbic oxytocin and arginine 8-vasopressin in morphine tolerance and dependence.

Authors:  G L Kovács; F Laczi; M Vecsernyés; K Hódi; G Telegdy; F A László
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

7.  Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice.

Authors:  Jia Qi; Jing-Yu Yang; Ming Song; Yan Li; Fang Wang; Chun-Fu Wu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

8.  Prosocial effects of oxytocin in two mouse models of autism spectrum disorders.

Authors:  Brian L Teng; Randal J Nonneman; Kara L Agster; Viktoriya D Nikolova; Tamara T Davis; Natallia V Riddick; Lorinda K Baker; Cort A Pedersen; Michael B Jarstfer; Sheryl S Moy
Journal:  Neuropharmacology       Date:  2013-05-03       Impact factor: 5.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.